Nivolumab Combined With SOX Used in the Perioperative Treatment

PHASE2RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Immune SuppressionGastric Cancer
Interventions
DRUG

nivolumab combined with SOX

nivolumab + SOX (3 cycles) before surgery → radical surgery (D2) → nivolumab + SOX (3 cycles) after surgery → nivolumab monotherapy maintenance (11 cycles);

Trial Locations (1)

310022

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
lead

Xiangdong Cheng

OTHER